Coya Therapeutics, Inc. (COYA) vs Neuraxis, Inc. (NRXS)
- Coya Therapeutics, Inc. COYA 4.27 −1.61%
- Neuraxis, Inc. NRXS 7.70 −0.52%
Coya Therapeutics, Inc. and Neuraxis, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Neuraxis, Inc. are of similar size ($101.8M and $97.2M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against 65.2%. Neuraxis, Inc. has the higher net margin (−159.0% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 16 metrics below, Coya Therapeutics, Inc. leads on 8 and Neuraxis, Inc. on 8.
Valuation
Profitability
| Metric | COYA | NRXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.56% | 65.16% |
| Operating margin | (288.70%) | (144.51%) | 0.00% |
| Net margin | (270.22%) | (159.01%) | 0.00% |
| Free cash flow margin | (221.64%) | (106.10%) | 0.00% |
| Return on equity | (60.54%) | (153.96%) | (56.36%) |
| Return on assets | (53.66%) | (98.96%) | (48.04%) |
| Return on invested capital | (15,230.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack